Genentech Sues Fresenius Kabi Over Generic Cancer Drug
Genentech Inc. has asked a Delaware federal court to block Fresenius Kabi USA LLC from releasing a generic version of the lung cancer drug Alecensa a decade before the patents expire....To view the full article, register now.
Already a subscriber? Click here to view full article